|Classification and external resources|
Lactic acidosis is a physiological condition characterized by low pH in body tissues and blood (acidosis) accompanied by the buildup of lactate, especially L-lactate, and is considered a distinct form of metabolic acidosis. Lactic acidosis is characterized by lactate levels >5 mmol/L and serum pH <7.35.
The condition typically occurs when cells receive too little oxygen (hypoxia), for example, during vigorous exercise. In this situation, impaired cellular respiration leads to lower pH levels. Simultaneously, cells are forced to metabolize glucose anaerobically, which leads to lactate formation. Therefore, elevated lactate is indicative of tissue hypoxia, hypoperfusion, and possible damage.
Signs and symptoms
The signs of lactic acidosis are deep and rapid breathing, vomiting, and abdominal pain. These symptoms are not specific for lactic acidosis. The deep breathing (Kussmaul breathing), which occurs in other types of metabolic acidosis, arises as an attempt to reduce blood acidity by exhaling carbon dioxide.
The list of signs and symptoms of lactic acidosis includes the following:
- Abdominal pain
- Severe anemia
- Irregular heart rate
The several different causes of lactic acidosis:
- Genetic conditions
Most cells in the body normally metabolize glucose to form water and carbon dioxide in a two-step process. First, glucose is broken down to pyruvate through glycolysis. Then, mitochondria oxidize the pyruvate into water and carbon dioxide by means of the Krebs cycle and oxidative phosphorylation. This second step requires oxygen. The net result is ATP, the energy carrier used by the cell to drive useful work, such as muscle contraction. When the energy in ATP is used during cell work via ATP hydrolysis, protons (positively charged hydrogen ions, or cations) are released. The mitochondria normally incorporate these free hydrogen nuclei back into ATP, thus preventing buildup of unbound hydrogen cations, maintaining neutral pH.
If oxygen supply is inadequate (hypoxia), the mitochondria are unable to continue ATP synthesis at a rate sufficient to supply the cell with the required ATP. In this situation, glycolysis is increased to provide additional ATP, and the excess pyruvate produced is converted into lactate and released from the cell into the bloodstream, where it accumulates over time. While increased glycolysis helps compensate for less ATP from oxidative phosphorylation, it cannot bind the hydrogen cations resulting from ATP hydrolysis. Therefore, hydrogen cation concentration rises and causes acidosis.
The excess hydrogen cations in lactic acidosis are widely believed to actually derive from production of lactic acid. This is incorrect, as cells do not produce lactic acid; pyruvate is converted directly into lactate, the anionic form of lactic acid. When excess intracellular lactate is released into the blood, maintenance of electroneutrality requires a cation to be released, as well. This can reduce blood pH. Glycolysis coupled with lactate production is neutral in the sense that it does not produce excess hydrogen cations, However, pyruvate production does produce them. Lactate production is buffered intracellularly, e.g. the lactate-producing enzyme lactate dehydrogenase binds one hydrogen cation per pyruvate molecule converted. When such buffer systems become saturated, cells will transport lactate into the bloodstream. Hypoxia certainly causes both buildup of lactate and acidification, and lactate is therefore a good "marker" of hypoxia, but lactate itself is not the cause of low pH. There is a view that in exercise and critical illness, lactate production is not generated by lack of oxygen but by catecholamine-driven glycolysis, and that the lactate serves as an energy source for other tissues.
Lactic acidosis sometimes occurs without hypoxia, for example, in rare inborn errors of metabolism where mitochondria do not function at full capacity. In such cases, when the body needs more energy than usual, for example during exercise or disease, mitochondria cannot match the cells' demand for ATP, and lactic acidosis results. Also, muscle types that have few mitochondria and preferentially use glycolysis for ATP production (fast-twitch or type II fibers) are naturally prone to lactic acidosis.
Lactic acidosis is an underlying process of rigor mortis. Tissue in the muscles of the deceased carry out anaerobic metabolism in the absence of oxygen, using muscle glycogen as the energy source, and significant amounts of lactic acid are released into the muscle tissue. With depletion of muscle glycogen, the loss of ATP causes the muscles to grow stiff, as the actin-myosin bonds cannot be released. (Rigor is later resolved by enzymatic breakdown of the myofibers.)
The Cohen-Woods classification categorizes causes of lactic acidosis as follows:
- Type A: Decreased perfusion or oxygenation
- Type B:
- B1: Underlying diseases (sometimes causing type A)
- B2: Medication or intoxication
- B3: Inborn error of metabolism
|This section requires expansion. (December 2013)|
Direct removal of lactate from the body (e.g. with hemofiltration) is difficult, and there is limited evidence for benefit. In type A lactic acidosis, treatment consists of effective management of the underlying cause, and there is limited evidence to support the use of sodium bicarbonate solutions to improve the pH (which is associated with increased carbon dioxide generation and may reduce the calcium levels).
In lactic acidosis secondary to medication, withdrawal of the medication may be necessary.
Lactic acidosis in the context of mitochondrial disorders (type B3) may be treated with a ketogenic diet and possibly with dichloroacetate (DCA), although this may be complicated by peripheral neuropathy and has a weak evidence base.
Reptiles, which rely primarily on anaerobic energy metabolism (glycolysis) for intense movements, can be particularly susceptible to lactic acidosis. In particular, during the capture of large crocodiles, the animals' use of their glycolytic muscles often alter the blood's pH to a point where they are unable to respond to stimuli or move. There are recorded cases in which particularly large crocodiles who put up extreme resistance to capture later died of the resulting pH imbalance.
Certain turtle species have been found to be capable of tolerating high levels of lactic acid without suffering the effects of lactic acidosis. Painted turtles hibernate buried in mud or underwater and do not resurface for the entire Winter. As a result they rely on anaerobic respiration to provide the majority of their energy needs. Adaptations in particular in the turtle's blood composition and shell allow it to tolerate high levels of lactic acid accumulation. In the anoxic conditions where anaerobic respiration is dominant, calcium levels in the blood plasma increase. This calcium serves as a buffer, reacting with the excess lactate to form the precipitate calcium lactate. It is suggested that this precipitate is reabsorbed by the shell and skeleton thereby removing it from the bloodstream; studies examining turtles who have been subjected to prolonged anoxic conditions have up to 45% of their lactate stored within their skeletal structure.
In ruminant livestock, the cause of clinically serious lactic acidosis is different from the causes described above.
In domestic ruminants, lactic acidosis may occur as a consequence of ingesting large amounts of grain, especially when the rumen population is poorly adapted to deal with grain. Activity of various rumen organisms results in accumulation of various volatile fatty acids (normally, mostly acetic, propionic and butyric acids), which are partially dissociated. Although some lactate is normally produced in the rumen, it is normally metabolized by such organisms as Megasphaera elsdenii and, to a lesser extent, Selenomonas ruminantium and some other organisms. With high grain consumption, the concentration of dissociated organic acids can become quite high, resulting in rumen pH dropping below 6. Within this lower pH range, Lactobacillus spp. (producing lactate and hydrogen ions) are favored, and M. elsdenii and S. ruminantium are inhibited, tending to result in a considerable rise of lactate and hydrogen ion concentrations in the rumen fluid. The pKa of lactic acid is low, about 3.9, versus, for example, 4.8 for acetic acid; this contributes to the considerable drop in rumen pH which can occur.
Because of the high solute concentration of the rumen fluid under such conditions, considerable water is translocated from the blood to the rumen along the osmotic potential gradient, resulting in dehydration which cannot be relieved by drinking, and which can ultimately lead to hypovolemic shock. As more lactate accumulates and rumen pH drops, the ruminal concentration of undissociated lactic acid increases. Undissociated lactic acid can cross the rumen wall to the blood, where it dissociates, lowering blood pH. Both L and D isomers of lactic acid are produced in the rumen; these isomers are metabolized by different metabolic pathways, and activity of the principal enzyme involved in metabolism of the D isomer declines greatly with lower pH, tending to result in an increased ratio of D:L isomers as acidosis progresses.
Measures for preventing lactic acidosis in ruminants include avoidance of excessive amounts of grain in the diet, and gradual introduction of grain over a period of several days, to develop a rumen population capable of safely dealing with a relatively high grain intake. Administration of lasalocid or monensin in feed can reduce risk of lactic acidosis in ruminants, inhibiting most of the lactate-producing bacterial species without inhibiting the major lactate fermenters. Also, using a higher feeding frequency to provide the daily grain ration can allow higher grain intake without reducing the pH of the rumen fluid.
Treatment of lactic acidosis in ruminants may involve intravenous administration of dilute sodium bicarbonate, oral administration of magnesium hydroxide, and/or repeated removal of rumen fluids and replacement with water (followed by reinoculation with rumen organisms, if necessary).
- Luft, FC (February 1, 2001). "Lactic acidosis update for critical care clinicians". Journal of the American Society of Nephrology 12 (Suppl. 17): 15–19. PMID 11251027. Retrieved 2008-05-28.
- Fimognari FL, Pastorelli R, Incalzi RA (April 2006). "Phenformin-induced lactic acidosis in an older diabetic patient: a recurrent drama (phenformin and lactic acidosis)". Diabetes Care 29 (4): 950–1. doi:10.2337/diacare.29.04.06.dc06-0012. PMID 16567854.
- Yang PW, Lin KH, Lo SH, Wang LM, Lin HD (February 2009). "Successful treatment of severe lactic acidosis caused by a suicide attempt with a metformin overdose". Kaohsiung J. Med. Sci. 25 (2): 93–7. doi:10.1016/S1607-551X(09)70047-6. PMID 19321413.
- McKenzie R, Fried MW, Sallie R et al. (1995). "Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B". N. Engl. J. Med. 333 (17): 1099–1105. doi:10.1056/NEJM199510263331702. PMID 7565947.
- P.W. Hochachka, T.P. Mommsen (1983). "Protons and anaerobiosis". Science 219 (4591): 1391–1397. doi:10.1126/science.6298937. PMID 6298937.
- R. Robergs, F. Ghiasvand, D. Parker (2004). "Biochemistry of exercise-induced metabolic acidosis". Am J Physiol Regul Integr Comp Physiol 287 (3): R502–16. doi:10.1152/ajpregu.00114.2004. PMID 15308499.
- Gladden, LB (Mar 2008). "Current trends in lactate metabolism: introduction". Medicine and science in sports and exercise 40 (3): 475–6. doi:10.1249/MSS.0b013e31816154c9. PMID 18379209.
- Woods, Hubert Frank; Cohen, Robert (1976). Clinical and biochemical aspects of lactic acidosis. Oxford: Blackwell Scientific. ISBN 0-632-09460-5.
- Cerdá, J; Tolwani, AJ; Warnock, DG (Jul 2012). "Critical care nephrology: management of acid-base disorders with CRRT.". Kidney international 82 (1): 9–18. doi:10.1038/ki.2011.243. PMID 21814173.
- Boyd, JH; Walley, KR (Aug 2008). "Is there a role for sodium bicarbonate in treating lactic acidosis from shock?". Current opinion in critical care 14 (4): 379–83. doi:10.1097/MCC.0b013e3283069d5c. PMID 18614899.
- Stacpoole, PW; Kurtz, TL; Han, Z; Langaee, T (2008). "Role of dichloroacetate in the treatment of genetic mitochondrial diseases". Advanced drug delivery reviews 60 (13–14): 1478–87. doi:10.1016/j.addr.2008.02.014. PMC 3746325. PMID 18647626.
- Pfeffer, G; Majamaa, K; Turnbull, DM; Thorburn, D; Chinnery, PF (2012). "Treatment for mitochondrial disorders". In Chinnery, Patrick F. The Cochrane database of systematic reviews 4: CD004426. doi:10.1002/14651858.CD004426.pub3. PMID 22513923.
- . Accessed 31 January 2009.
- Jackson, Donald C. (2002). "Hibernating without oxygen: physiological adaptations of the painted turtle". The Journal of Physiology 543 (3): 731–737. doi:10.1113/jphysiol.2002.024729. PMC 2290531. PMID 12231634. Retrieved 2014-03-16.
- Kimberling, C. V. 1988. Jensen and Swift's diseases of sheep. 3rd Ed. Lea & Fibiger, Philadelphia. 394 pp.
- Pugh, D. G. 2002. Sheep and goat medicine. Saunders. 468 pp.
- Kahn, C. M. (ed.) 2005. Merck veterinary manual. 9th Ed. Merck & Co., Inc., Whitehouse Station.
- Van Soest, P. J. 1994. Nutritional ecology of the ruminant. 2nd Ed. Cornell Univ. Press, Ithaca. 476 pp.
- Nocek, J. E. 1997. Bovine acidosis: implications on laminitis. J. Dairy Sci. 80: 1005-1028.
- Owens, F. N., D. S. Secrist, W. J. Hill and D. R. Gill. 1998. Acidosis in cattle: a review. J. Anim. Sci. 76: 275-286.
- Nagaraja, T. G., T. B. Avery, E. E. Bartley, S. J. Galitzer and A. D. Dayton. 1981. Prevention of lactic acidosis in cattle by lasalocid or monensin. J. Anim. Sci. 53: 206-216.
- Dennis, S. M., T. G. Nagaraja and E. E. Bartley. 1981. Effect of lasalocid or monensin on lactate-producing or -using rumen bacteria. J. Anim. Sci. 53: 418-426.
- Kaufmann, W. 1976. Influence of the composition of the ration and the feeding frequency on ph-regulation in the rumen and on feed in-take in ruminants. Livestock Prod. Sci. 3: 103-114.